Animal Technician, Preclinical Studies

Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel (CAP-1002), our lead cell therapy in late-stage development for Duchenne muscular dystrophy. We are also harnessing our proprietary StealthX™ exosome platform to unlock new possibilities in targeted delivery and vaccinology. Every program reflects our commitment to pushing the boundaries of science and delivering life-changing treatments to patients and families who need them most.

The Animal Technician will be responsible for performing in vivo studies including compound dosing, sample collection and analysis for data generation. The position will afford the opportunity to work alongside a highly dynamic and collaborative team to develop an entirely new therapeutic modality.